Alexander Nowak
Stock Analyst at Craig-Hallum
(2.71)
# 1,859
Out of 5,140 analysts
46
Total ratings
45.95%
Success rate
6.93%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $96 → $108 | $106.78 | +1.14% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $5.28 | +316.67% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $216.36 | -27.44% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $8.60 | +97.67% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $23.61 | +141.42% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $19.87 | -24.51% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $8.50 | -5.88% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.42 | +1,167.61% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $18.52 | +169.98% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $11.43 | +1,299.83% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $103.29 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.71 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.08 | +428.85% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $58.25 | +88.84% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $8.21 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $1.63 | +18,304.91% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $7.90 | +254.43% | 1 | Aug 31, 2020 |
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $106.78
Upside: +1.14%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $5.28
Upside: +316.67%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $216.36
Upside: -27.44%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $8.60
Upside: +97.67%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $23.61
Upside: +141.42%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $19.87
Upside: -24.51%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $8.50
Upside: -5.88%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.42
Upside: +1,167.61%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $18.52
Upside: +169.98%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $11.43
Upside: +1,299.83%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $103.29
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.71
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.08
Upside: +428.85%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $58.25
Upside: +88.84%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $8.21
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $1.63
Upside: +18,304.91%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $7.90
Upside: +254.43%